SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-20-003507
Filing Date
2020-02-13
Accepted
2020-02-13 11:23:30
Documents
1
Group Members
PONTIFAX (CAYMAN) II L.P.PONTIFAX (ISRAEL) II L.P.PONTIFAX MANAGEMENT 2 G.P. (2007) LTD.PONTIFAX MANAGEMENT II L.P.TOMER KARIV

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g0220pontifax_kitovpharm.htm SC 13G 162516
  Complete submission text file 0001213900-20-003507.txt   164165
Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
Nussbaum Ran (Filed by) CIK: 0001609805 (see all company filings)

Type: SC 13G

Mailing Address ONE AZRIELI CENTER, ROUND TOWER 132 MENACHEM BEGIN ROAD TEL AVIV L3 6701101
Business Address ONE AZRIELI CENTER, ROUND TOWER 132 MENACHEM BEGIN ROAD TEL AVIV L3 6701101 97239333121
Kitov Pharma Ltd. (Subject) CIK: 0001614744 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89209 | Film No.: 20607953
SIC: 2834 Pharmaceutical Preparations